10291 related articles for article (PubMed ID: 1835714)
1. Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactions.
Radrizzani M; Benedetti B; Castelli C; Longo A; Ferrara GB; Herlyn M; Parmiani G; Fossati G
Int J Cancer; 1991 Dec; 49(6):823-30. PubMed ID: 1835714
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL
Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596
[TBL] [Abstract][Full Text] [Related]
3. A CD4+, HLA-DR7-restricted T-helper lymphocyte clone recognizes an antigen shared by human malignant melanoma and glioma.
Somasundaram R; Swoboda R; Caputo L; Lee A; Jackson N; Marincola FM; Guerry D; Herlyn D
Int J Cancer; 2003 Apr; 104(3):362-8. PubMed ID: 12569560
[TBL] [Abstract][Full Text] [Related]
4. Classification of CD4+ T helper cell clones in human melanoma.
Goedegebuure PS; Lee KY; Matory YL; Peoples GE; Yoshino I; Eberlein TJ
Cell Immunol; 1994 Jun; 156(1):170-9. PubMed ID: 7911074
[TBL] [Abstract][Full Text] [Related]
5. Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy.
Kan-Mitchell J; Huang XQ; Steinman L; Oksenberg JR; Harel W; Parker JW; Goedegebuure PS; Darrow TL; Mitchell MS
Cancer Immunol Immunother; 1993 Jul; 37(1):15-25. PubMed ID: 8513449
[TBL] [Abstract][Full Text] [Related]
6. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
7. Alloantigen-specific cytotoxic clones bearing the alpha,beta T cell antigen receptor but not CD4 or CD8 molecules.
Rivas A; Koide J; Laus R; Engleman EG
J Immunol; 1990 Jul; 145(2):470-6. PubMed ID: 2142178
[TBL] [Abstract][Full Text] [Related]
8. Detection of melanoma-reactive CD4+ HLA-class I-restricted cytotoxic T cell clones with long-term assay and pretreatment of targets with interferon-gamma.
LeMay LG; Kan-Mitchell J; Goedegebuure P; Harel W; Mitchell MS
Cancer Immunol Immunother; 1993 Aug; 37(3):187-94. PubMed ID: 8101473
[TBL] [Abstract][Full Text] [Related]
9. Clonal analysis of cytotoxic T-lymphocyte response to autologous human metastatic melanoma.
Anichini A; Fossati G; Parmiani G
Int J Cancer; 1985 May; 35(5):683-9. PubMed ID: 3158614
[TBL] [Abstract][Full Text] [Related]
10. Human CD4+ T cells proliferate to HLA-DR+ allogeneic vascular endothelium. Identification of accessory interactions.
Savage CO; Hughes CC; McIntyre BW; Picard JK; Pober JS
Transplantation; 1993 Jul; 56(1):128-34. PubMed ID: 7687392
[TBL] [Abstract][Full Text] [Related]
11. Specificity of human T lymphocytes expressing a gamma/delta T cell antigen receptor. Recognition of a polymorphic determinant of HLA class I molecules by a gamma/delta clone.
Ciccone E; Viale O; Pende D; Malnati M; Battista Ferrara G; Barocci S; Moretta A; Moretta L
Eur J Immunol; 1989 Jul; 19(7):1267-71. PubMed ID: 2527158
[TBL] [Abstract][Full Text] [Related]
12. T-cell clones that react against autologous human tumors.
Mukherji B; Chakraborty NG; Sivanandham M
Immunol Rev; 1990 Aug; 116():33-62. PubMed ID: 2146210
[TBL] [Abstract][Full Text] [Related]
13. Evidence for involvement of the gamma, delta T cell antigen receptor in cytotoxicity mediated by human alloantigen-specific T cell clones.
Rivas A; Koide J; Cleary ML; Engleman EG
J Immunol; 1989 Mar; 142(6):1840-6. PubMed ID: 2466078
[TBL] [Abstract][Full Text] [Related]
14. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP.
Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM
J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208
[TBL] [Abstract][Full Text] [Related]
15. MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC).
Wang P; Vánky F; Klein E
Int J Cancer; 1992 Jul; 51(6):962-7. PubMed ID: 1386348
[TBL] [Abstract][Full Text] [Related]
16. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
[TBL] [Abstract][Full Text] [Related]
17. Human atopen-specific types 1 and 2 T helper cell clones.
Wierenga EA; Snoek M; Jansen HM; Bos JD; van Lier RA; Kapsenberg ML
J Immunol; 1991 Nov; 147(9):2942-9. PubMed ID: 1680923
[TBL] [Abstract][Full Text] [Related]
18. Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones.
Koide J; Engleman EG
J Immunol; 1990 Jan; 144(1):32-40. PubMed ID: 1967266
[TBL] [Abstract][Full Text] [Related]
19. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the donor-specific cytotoxic T lymphocyte repertoire in a patient with a long term surviving allograft. Frequency, specificity, and phenotype of donor-reactive T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ clones.
Vandekerckhove BA; Datema G; Koning F; Goulmy E; Persijn GG; Van Rood JJ; Claas FH; De Vries JE
J Immunol; 1990 Feb; 144(4):1288-94. PubMed ID: 2137487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
